Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/158951
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.
Subject
Subject (English)
Citation
Citation
DE LA TORRE, Beatriz G. and ALBERICIO PALOMERA, Fernando. The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules. 2018. Vol. 23, num. 3, pags. 533. ISSN 1420-3049. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/158951